Skip to main content
ITACONIX PLC logo

ITACONIX PLC — Investor Relations & Filings

Ticker · ITX ISIN · GB00BPK3YZ68 LEI · 213800OKA3GOCK2ZA496 IL Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2023-02-23 Major Shareholding Noti…
Country GB United Kingdom
Listing IL ITX

About ITACONIX PLC

https://www.itaconix.com

Itaconix PLC is an innovator in sustainable, plant-based polymers derived from itaconic acid. The company develops, manufactures, and markets specialty ingredients used to decarbonize everyday consumer products. Its products serve as high-performance, eco-friendly alternatives to conventional fossil-based compounds in the home care, personal care, and beauty markets. Key offerings include performance additives that provide benefits such as scale inhibition (Itaconix® TSI® 322) and permanent odor neutralization (Itaconix® ONZ™ 400). The company also provides turnkey formulated solutions for cleaning and hygiene products, as well as specialty itaconate monomers (BIO*Asterix®) for industrial applications like paints, coatings, and adhesives. Itaconix focuses on improving the safety, performance, and renewability of consumer goods.

Recent filings

Filing Released Lang Actions
TR-1
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number : 7728Q" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a TR-1 form, which is a 'Standard form for notification of major holdings' due to an acquisition or disposal of voting rights by a shareholder (Octopus Investments Limited). This type of mandatory disclosure regarding changes in significant share ownership thresholds directly corresponds to the Major Shareholding Notification category.
2023-02-23 English
Results of Open Offer, GM and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an RNS announcement (RNS Number : 7408Q) dated February 22, 2023, reporting on the 'Results of Open Offer, General Meeting and Total Voting Rights'. Crucially, the latter half of the document details transactions by PDMRs (Persons Discharging Managerial Responsibilities) including the CEO, CFO, and Non-Executive Chair, specifying the 'Nature of the transaction' as 'Purchase of New Ordinary Shares' and providing transaction dates (27 February 2023) and prices. This structure, detailing insider trades following a corporate action (Open Offer/Placing), strongly indicates a filing related to director dealings under market abuse regulations (MAR). Therefore, the most appropriate classification is Director's Dealing (DIRS). Although it contains AGM results, the primary focus of the detailed tables is insider transactions.
2023-02-22 English
Investor Presentation following GM on 22 Feb 2023
Investor Presentation Classification · 1% confidence The document is an RNS announcement (RNS Number : 9330P) dated February 15, 2023. The core subject is the announcement of a live investor presentation scheduled to follow a General Meeting on February 22, 2023. This presentation is explicitly described as an 'Investor Presentation'. This aligns directly with the definition for Investor Presentation (IP). Although it is distributed via RNS, the specific content points to IP rather than a general regulatory filing (RNS) or a report publication announcement (RPA), as it details the event itself (who, when, how to join) rather than just stating a report is attached or published. The document length (4615 chars) is substantial enough to be the primary announcement, not just a brief notice.
2023-02-15 English
Placing, Subscription and Open Offer; Notice of GM
Regulatory Filings Classification · 1% confidence The document is an RNS announcement dated February 3, 2023, detailing a 'Placing, Subscription and Open Offer' which constitutes a fundraising activity aimed at raising approximately £10.3 million plus an additional £0.4 million via an Open Offer. It explicitly mentions that the completion of the fundraising is conditional upon Shareholder Resolutions being passed at a General Meeting, and it includes a 'Notice of General Meeting' and references an expected 'Circular'. The core subject is the capital raising (£10.3M + £0.4M) and the associated shareholder vote required to approve part of it. This strongly aligns with the 'Capital/Financing Update' (CAP) category, as it is a detailed announcement of a fundraising effort. While it mentions a General Meeting and a Circular, the primary driver and focus of the announcement is the capital raise itself, not just the meeting logistics (which would lean towards AGM-R or PSI). Since it is a detailed announcement of a financing event, CAP is the most appropriate primary classification. It is not a general regulatory filing (RNS) because it fits a specific category (CAP).
2023-02-03 English
Board Change
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (Regulatory News Service) on January 5, 2023. The core content explicitly states: 'Itaconix plc... is pleased to announce changes to the Board.' It details the appointment of Paul LeBlanc as an independent Non-Executive Director and the permanent appointment of Dr. Peter Nieuwenhuizen as Non-Executive Chair. This directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification.
2023-01-05 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 chars) and begins with 'RNS Number : 8089I'. It discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure and content strongly indicate a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the appropriate fallback is Regulatory Filings (RNS).
2022-12-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.